Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

DSM-Firmenich opens office in Jakarta and expands plant in Karawang

DSM-Firmenich is expanding its presence in Indonesia: the new Jakarta office brings together the teams for Taste, Texture & Health, Perfumery & Beauty and Health, Nutrition & Care. At the same time, the production site in Karawang was expanded with drying equipment and additional blending capacity for culinary products. The plant runs entirely on renewable electricity; electric heating systems are expected to reduce CO2 emissions by around 300 tonnes per year, and heat recovery should cut energy consumption by about 16 percent. The company has been active in Indonesia for more than 35 years, which is considered one of the most important markets in Southeast Asia. » More on finanzen.net
DSM-Firmenich starts collaboration with AI start-up Boltz on biomolecular modeling

DSM-Firmenich has agreed a partnership with AI start-up Boltz to integrate Boltz’s proprietary base models into the discovery of new ingredients. The AI models will be combined with DSM-Firmenich’s database of taste and smell receptors to predict and design molecular structures. The aim is a deeper understanding of interactions between molecules and specialized proteins to develop new fragrance and flavor molecules. » More on finanzen.net
Inge Massen-Biemans becomes chief sustainability officer at DSM-Firmenich

Inge Massen-Biemans will assume the role of chief sustainability officer at DSM-Firmenich on 1 November 2026, succeeding Katharina Stenholm, who will leave the company at the end of 2026. Massen-Biemans has been with the company for 25 years, is currently vice president Nutrition, Health & Social Impact, and previously worked in Corporate & Public Affairs. She will remain country head for the Netherlands and, as CSO, will report directly to CEO Dimitri de Vreeze. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, DSM-Firmenich has already paid €2.50 in dividends. The last payout was in May.

Financials

In the last quarter, DSM-Firmenich had revenue of €4.66bn and net profit of €212m

(EUR)	June 2026	YoY
Revenue	4.66bn	43.29%
Gross profit	1.91bn	60.50%
Net profit	212m	16.86%
EBITDA	887m	29.87%

Fundamentals

Metric	Value
Market capitalization	€26.61bn
Number of shares	244.36m
52-week high/low	€109.85 - €55.22
Dividend yield	2.30%
Dividends TTM	€2.50
Beta	0.55
P/E ratio	-22.59
PEG ratio	0.10
P/B ratio	1.53
P/S ratio	2.80

Company profile

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.

Name	DSM-Firmenich
CEO	Dimitri de Vreeze
Headquarters	Kaiseraugst, ag Switzerland
Website	dsm-firmenich.com/corporate/home.html
Sector	Materials
Industry	Chemicals
IPO	18/04/2023
Employees	28,550